Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)-Reference-Cited by-同舟云学术

Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

Published:2009-06 Issue:6 Volume:47 Page:1942-1946
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Messer Shawn A.¹,Moet Gary J.¹,Kirby Jeffrey T.¹,Jones Ronald N.¹²

Affiliation:

1. JMI Laboratories, North Liberty, Iowa

2. Tufts University School of Medicine, Boston, Massachusetts

Abstract

ABSTRACT Results from the SENTRY international fungal surveillance program for 2006 to 2007 are presented. A total of 1,448 Candida sp., 49 Aspergillus fumigatus , and 33 Cryptococcus neoformans isolates were obtained from infected sterile-site sources in patients on five continents. Reference susceptibility was determined for anidulafungin, caspofungin, 5-flucytosine, fluconazole, itraconazole, posaconazole, voriconazole, and amphotericin B by CLSI methods.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02434-08

Reference17 articles.

1. M27-A3 reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard third edition. 2008

2. M27-S3 reference method for broth dilution antifungal susceptibility testing of yeasts; third informational supplement. 2008

3. M38-A2 reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard second edition. 2008

4. Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against Molds

5. Hazen, K. C., and S. A. Howell. 2007. Candida, Cryptococcus, and other yeasts of medical importance, p. 1762-1788. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. American Society for Microbiology, Washington, DC.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micelle-like Nanoassemblies of Short Peptides Create Antimicrobial Selectivity in a Conventional Antifungal Drug;ACS Applied Nano Materials;2022-12-23

2. Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature;American Journal of Clinical Dermatology;2022-04-15

3. The glyoxylate cycle and alternative carbon metabolism as metabolic adaptation strategies of Candida glabrata: perspectives from Candida albicans and Saccharomyces cerevisiae;Journal of Biomedical Science;2019-07-13

4. Application of pulsed electric fields for the elimination of highly drug-resistant Candida grown under modelled microgravity conditions;International Journal of Astrobiology;2018-09-04

5. Does the use of antifungal agents in agriculture and food foster polyene resistance development? A reason for concern;Journal of Global Antimicrobial Resistance;2018-06